Quadraned Snags Another McKesson Executive

Quadramed today announced the appointment of Michael J. Simpson, a former McKesson executive, to the post of Senor Vice President, Product Strategy and Development. As part of his signing, he was granted warrants controlling 90,000 shares of QDHC common stock. He becomes the second executive, along with CEO Duncan James, to be brought on by the Quadramed Board of Directors from McKesson, a $16,000,000,000 health care and information technology behemoth. In my view, this is another good sign that the Board of Directors is serious about turning this company around after a prolonged period of lackluster results. To learn more about my reasons for owning QDHC NOW read my blog entry dated July 28, 2009. Quadramed hasn't done much since my profile on it last July, but I do believe it is well positioned to take advantage of the billions of Obama dollars put forth in the stimulus package with the goal of automating the health care industry. Apparently so do two former executives of McKesson. Do your own DD.